MACROBIAN-BIOTECH
Macrobian-Biotech aims at performing clinical research and treatments for disorders affecting the dopamine system.
MACROBIAN-BIOTECH
Social Links:
Industry:
Biotechnology Clinical Trials Neuroscience
Founded:
2017-01-01
Address:
Amsterdam, Noord-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.macrobian-biotech.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
OVH Instra
Similar Organizations
Balter Medical
Balter Medical is an optical imaging company that develops devices to aid tissue diagnostics.
Fondazione Neurone Onlus
Fondazione Neurone Onlus offers financial support in study and research for treating neurological and psychiatric diseases.
Official Site Inspections
http://www.macrobian-biotech.com
Unable to get host informations!!!
More informations about "Macrobian-Biotech"
Macrobian-Biotech - Crunchbase Company Profile & Funding
Macrobian-Biotech aims at performing clinical research and treatments for disorders affecting the dopamine system.See details»
Macrobian Biotech BV - Crunchbase Company Profile & Funding
Where is Macrobian Biotech BV's headquarters? Macrobian Biotech BV is located in Amsterdam, Noord-Holland, The Netherlands. Who invested in Macrobian Biotech BV? Macrobian Biotech …See details»
Macrobian Biotech - PitchBook
Macrobian Biotech is a Private company. What is Macrobian Biotech’s current revenue? The current revenue for Macrobian Biotech is . Who are Macrobian Biotech’s investors? Innovation …See details»
Macrobian Biotech BV - VentureRadar
"Macrobian-Biotech was founded in May 2017 by Dr. Lars van der Heide and Prof. dr. Marten Smidt. Its primary goal is to perform pre-clinical research that leads to noval treatments for …See details»
Macrobian-Biotech - Company Profile - Tracxn
Macrobian-Biotech - Developer of treatments for neurological and neuropsychiatric diseases. Raised funding from 1 investor.See details»
Macrobian Biotech - LinkedIn
Macrobian Biotech was founded in May 2017 by Dr. Lars van der Heide and Prof. dr. Marten Smidt. With decades of collective experience in molecular neuroscience, the founders recognized the urgent ...See details»
Macrobian Biotech BV - Amsterdam UMC Ventures Holding
Macrobian Biotech BV Macrobian Biotech BV is een spin-off bedrijf van de Universiteit van Amsterdam. Marcobian Biotech BV is opgericht in mei 2017 door Dr. Lars van der Heide …See details»
Macrobian Biotech BV - Funding, Financials, Valuation & Investors
May 15, 2017 Macrobian Biotech BV has raised 2 rounds. Their latest funding was raised on May 15, 2017 from a Pre-Seed round. Macrobian Biotech BV is funded by 2 investors. UvA …See details»
Macrobian Biotech Company Profile | Management and …
Find contact information for Macrobian Biotech. Learn about their Research & Development, Business Services market share, competitors, and Macrobian Biotech's email format.See details»
Macrobian Biotech BV - Drug pipelines, Patents, Clinical trials
Explore Macrobian Biotech BV with its drug pipeline, therapeutic area, technology platform, 1 literature.See details»
Full List of Biotech Companies in Amsterdam (2025)
Jan 24, 2025 Top biotech companies in Amsterdam include Inbiome, Scenic Biotech, Macrobian Biotech, CureVac, and VectorY. The city is home to Amsterdam Science Park, where there …See details»
Macrobian-Biotech - Products, Competitors, Financials, Employees ...
About Macrobian-Biotech Macrobian-Biotech focuses on developing novel treatments for Parkinson's disease within the biotechnology sector. The company's main offerings include …See details»
Macrobian-Biotech - Founders and Board of Directors - Tracxn
Feb 22, 2025 Macrobian-Biotech founders & board of directors Developer of treatments for neurological and neuropsychiatric diseases 2017 • Amsterdam (Netherlands) • Funding RaisedSee details»
Macrobian-Biotech: Drug pipelines, Patents, Clinical trials - Synapse
Explore Macrobian-Biotech with its drug pipeline, therapeutic area, technology platform, .See details»
Macrobian Biotech - Overview - aiHit
Macrobian Biotech was founded in May 2017 by Dr. Lars van der Heide and Prof. dr. Marten Smidt. With decades of collective experience in molecular neuroscience, the founders …See details»
UvA spin-off Macrobian Biotech secures seed investment
Feb 13, 2025 Macrobian Biotech’s lead compound, known as MB-101, targets endogenous dopamine production and uptake with high spatiotemporal specificity, overcoming the need for …See details»
Amsterdam Science Park spotlight: UvA-Macrobian-Biotech …
Science & Business interviews Marten Smidt, CEO of Macrobian Biotech about the development of revolutionary Parkinson's drugs. Read the full interview here.See details»
New directors of Amsterdam Neuroscience
Feb 8, 2022 Smidt is the founder and CEO of Macrobian Biotech, a spin-off company that develops novel medication to treat and stop Parkinson’s disease progression. As co-director of …See details»
GUCY2C (Macrobian) - Drug Targets, Indications, Patents - Synapse
Mar 20, 2025 GUCY2C (Macrobian): a GC-C modulators Drug, Initially developed by Macrobian-Biotech, Now, its global highest R&D status is Preclinical, Mechanism: GC-C modulators (Heat …See details»
MassBio Recognizes Life Sciences Companies, Leaders with …
1 day ago MassBio is the driving force behind Massachusetts’ life sciences ecosystem, supporting innovation and industry growth by offering best-in-class resources to over 1,700 …See details»